Psychiatric disorder and cognitive impairment in systemic lupus erythematosus

scientific article published on April 1992

Psychiatric disorder and cognitive impairment in systemic lupus erythematosus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.1780350409
P698PubMed publication ID1567490

P2093author name stringBernstein RM
Black D
Creed F
Holt PJ
Hay EM
Huddy A
Tomenson B
P2860cites workThe study of the psychiatric symptoms of systemic lupus erythematosus. A biometric study.Q52120537
Verbal fluency as a function of a measure of verbal intelligence and in relation to different types of cerebral pathology.Q52276226
The Occurrence of Psychiatric Illness in Systemic Lupus ErythematosusQ46438390
The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patientsQ48369404
psychiatric symptoms in patients with systemic lupus erythematosus.Q52102406
P433issue4
P921main subjectcognitive dysfunctionQ57859955
systemic lupus erythematosusQ1485
P304page(s)411-416
P577publication date1992-04-01
P1433published inArthritis & RheumatologyQ4797636
P1476titlePsychiatric disorder and cognitive impairment in systemic lupus erythematosus
P478volume35

Reverse relations

cites work (P2860)
Q41647250A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus
Q52031265Altered levels of neuropeptides characterize the brain of lupus prone mice.
Q47825982An investigation in the possible effect of chronic headache on neuropsychological function in aCL-negative patients with SLE.
Q34059923Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes
Q71775354Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus
Q48465933Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus
Q24805595Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies
Q48115169Brain reactive autoantibodies and cognitive impairment in systemic lupus erythematosus
Q48334054Brain synaptosomal antibodies in systemic lupus erythematosus
Q37019825Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus
Q48280000Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations
Q40584328Changes in the clinical and laboratory features of lupus patients after the big earthquake in Taiwan
Q88094564Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis
Q40827014Cognitive changes in systemic lupus erythematosus
Q35625220Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus
Q55305136Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study.
Q36434125Cognitive dysfunction in the patient with antiphospholipid antibodies: considerations for cause and treatment
Q48961470Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity
Q33567067Controversies in lupus: nervous system involvement
Q38660157Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE)
Q46152193DSM-III-R classification of psychiatric symptoms in systemic lupus erythematosus
Q39930637Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study
Q47915544Depression in systemic lupus erythematosus patients is associated with link-polymorphism but not methylation status of the 5HTT promoter region
Q44289531Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study
Q31933342Evaluation of patients with CNS involvement in SLE.
Q38650121Gulf War illness (GWI) as a neuroimmune disease
Q32064256Identification and cloning of a brain autoantigen in neuro-behavioral SLE.
Q51986532Lateralized cognitive dysfunction in patients with systemic lupus erythematosus.
Q44752066Learning and memory-related brain activity dynamics are altered in systemic lupus erythematosus: a functional magnetic resonance imaging study.
Q40416808Major life stress, coping styles, and social support in relation to psychological distress in patients with systemic lupus erythematosus
Q40929944Nervous system lupus: pathogenesis and rationale for therapy
Q34213820Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage
Q34075832Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience
Q33566498Neuropsychological analysis in patients with systemic lupus erythematosus: a case control study
Q33339985Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis
Q36392300Neuropsychological patterns in systemic lupus erythematosus patients with depression
Q51069301Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations.
Q47802635Prevalence and severity of depression and anxiety in patients with systemic lupus erythematosus: An epidemiologic study in Iranian patients
Q34160129Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience
Q36896792Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials
Q57089661Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system
Q51074622Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease.
Q41032402Psychiatric disorder and cognitive impairment in SLE.
Q37768381Quality-of-life measurements versus disease activity in systemic lupus erythematosus
Q40519956Rehabilitation in joint and connective tissue diseases. 1. Systemic diseases
Q40926905Research methods for investigating causal relations between SLE disease variables and psychiatric symptomatology.
Q84078404SLE-related longitudinal myelitis with favorable outcome
Q38459101Site differences in mild cognitive dysfunction (MCD) among patients with systemic lupus erythematosus (SLE).
Q34085879Stress and rheumatic diseases.
Q50913353Stress as a predictor of cognitive functioning in lupus.
Q48079385Symptoms of attention deficit hyperactivity disorder in patients with systemic lupus erythematosus.
Q41025088Systemic lupus erythematosus patients with past neuropsychiatric involvement are associated with worse cognitive impairment: a longitudinal study.
Q46713726The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE.
Q48220131The etiology of psychiatric symptoms in patients with systemic lupus erythematosus.
Q33808136The psychiatric side effects of corticosteroids
Q52002948Working memory and processing speed deficits in systemic lupus erythematosus as measured by the paced auditory serial addition test.
Q73200543[Autoimmunity: a concept to be revisited?]
Q73209075[Psychoimmunology: a questionable model?]

Search more.